Retina Synthesis

Retina Synthesis

Retina Synthesis is a data-focused resource exploring therapies in development for retinal diseases.

  1. VOR 7 STD.

    The PRIMA Retinal Implant for Geographic Atrophy

    In our latest episode, we discuss the results of the PRIMA retinal implant in treating eyes with center involved geographic atrophy as presented in a recent New England Journal of Medicine article. 85% of eyes had meaningful improvement in vision at one year with Dr. Daniel Palanker, Professor of Ophthalmology and Electrical Engineering, Stanford University.

    23 Min.

  2. 17. FEB.

    The New Day Trial of Iluvien for DME

    In this episode, In our latest episode,  we discuss the results of a randomized trial comparing the Iluvien sustained release steroid implant to aflibercept in the treatment of diabetic macular edema with Dr. Michael Singer, Clinical Professor, University of Texas Health Sciences Center, San Antonio.

    13 Min.

  3. 10. FEB.

    Photodynamic Therapy of Central Serous Chorioretinopathy

    We discuss the diagnosis and management of central serous chorioretinopathy with photodynamic therapy with Dr. Andrew Lotery, Professor of Ophthalmology, University of Southhampton, United Kingdom.

    30 Min.

  4. 4. FEB.

    Cooling Anesthesia for Intravitreal Injection

    In this episode, we discuss the use of low dose cryogenic application for anesthesia prior to intravitreal injection with Dr. Michael Singer, Adjunct Professor University of Texas Health Science Center, San Antonio.

    14 Min.

  5. 27. JAN.

    New Developments in Treating ROP

    In our latest update, we discuss current treatment of retinopathy of prematurity as well as new developments in disease prevention with Dr. Darius Moshfeghi, Professor of Ophthalmology, Stanford University, Director, Retina Division, Byers Eye Institute.

    24 Min.

  6. 20. JAN.

    TKI Drugs in the Treatment of nAMD and DME

    In this update, we review the TKI program of Eyepoint Pharmaceuticals with Dr. Jay Duker, President and CEO.

    17 Min.

  7. 13. JAN.

    Artificial Intelligence and Home OCT for nAMD

    We discuss a study that showed that an artificial intelligence powered system can detect clinically significant fluid as well as experienced observers using the Notal Home OCT with Dr. Ted Leng, Professor of Ophthalmology, Byers Eye Institute, Stanford University.

    10 Min.

  8. 6. JAN.

    Undertreatment of Diabetic Macular Edema: A Clinical Challenge

    We discuss studies documenting the undertreatment of diabetic macular edema and possible strategies for alleviating it with Dr. Matthew Starr, Assistant Professor, Mayo Clinic, Rochester, Minnesota.

    13 Min.
Alle anzeigen (169)

Info

Retina Synthesis is a data-focused resource exploring therapies in development for retinal diseases.

Informationen

  • Erstellt von
    Retina Synthesis
  • Jahre aktiv
    2021 - 2026
  • Folgen
    169
  • Bewertung
    Unbedenklich
  • Copyright
    © 2026 Retina Synthesis
  • Sendungswebsite
    Retina Synthesis

Das gefällt dir vielleicht auch